MELIS, Michela
 Distribuzione geografica
Continente #
NA - Nord America 109
EU - Europa 76
AS - Asia 40
Totale 225
Nazione #
US - Stati Uniti d'America 109
UA - Ucraina 33
CN - Cina 29
IT - Italia 16
DE - Germania 12
CZ - Repubblica Ceca 7
FR - Francia 6
SG - Singapore 6
TR - Turchia 5
FI - Finlandia 1
SE - Svezia 1
Totale 225
Città #
Chandler 25
Jacksonville 24
Princeton 12
Dearborn 10
Sassari 10
Brno 7
Nanjing 7
Nanchang 6
Izmir 4
Singapore 4
Wilmington 4
Shenyang 3
Cagliari 2
Changsha 2
Hebei 2
Jiaxing 2
Kunming 2
Beijing 1
Haikou 1
Jinan 1
Norwalk 1
San Francisco 1
San Giovanni Lupatoto 1
Tianjin 1
Zhengzhou 1
Totale 134
Nome #
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 50
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 50
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 44
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 36
Erratum to: Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel (Infection, (2017), 45, 2, (131-138), 10.1007/s15010-016-0973-0) 31
Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life 31
Totale 242
Categoria #
all - tutte 1.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.372


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202044 0 0 1 0 6 9 11 1 7 3 6 0
2020/202141 6 0 6 0 6 0 6 0 10 6 1 0
2021/202221 2 1 0 0 0 0 0 2 0 2 5 9
2022/202352 8 2 5 3 2 10 0 7 10 0 3 2
2023/202413 4 1 0 0 3 0 0 0 0 0 1 4
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 242